ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation headquartered in Newark, New York, filed this Current Report on Form 8-K on August 7, 2025. The filing serves to announce the financial results for the second quarter ended June 30, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the provided text.
Material Changes
No material changes versus the prior comparable period are detailed in the body of this Form 8-K. The document solely references the issuance of the press release containing the comparative financial data.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, contingencies, or descriptions of unusual items. Such information is expected to be found in the referenced Exhibit 99.1 press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 7, 2025) for specific Q2 2025 revenue and earnings figures.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any updated full-year 2025 guidance or outlook statements in the press release.
- Confirm the absence of any restatements or material adjustments to prior periods in the full disclosure.